Inventor · disambiguated record
George F. Vande Woude
Also filed as: KOO LEGAL REPRESENTATIVE EUNMI KAY · VANDE WOUDE GEORGE · VANDE WOUDE GEORGE F
14 granted patents·7 pending applications·641 citations·filing 1981–2011
93Inventor score
Top patents by PatentIndex Score
21 records- 0194US4405712ALTR-VectorsUS HEALTH·Filed 1981·Granted Sep 20, 1983·319 cites·10 claims
- 0288US8309315B2Monoclonal antibody which binds cMet (HGFR) in formalin-fixed and paraffin-embedded tissues and related methodsCAO BOLIANG·Filed 2008·Granted Nov 13, 2012·27 cites·21 claims
- 0388US5645988AMethods of identifying drugs with selective effects against cancer cellsUS HEALTH·Filed 1994·Granted Jul 8, 1997·147 cites·19 claims
- 0487US7892770B2Monoclonal antibody which binds cMet (HGFR) in formalin-fixed and paraffin-embedded tissues and related methodsVAN ANDEL RES INST·Filed 2007·Granted Feb 22, 2011·38 cites·16 claims
- 0578US5648273AHepatic growth factor receptor is the MET proto-oncogeneUS HEALTH·Filed 1991·Granted Jul 15, 1997·43 cites·2 claims
- 0671US7872117B2c-met siRNA adenovirus vectors inhibit cancer cell growth, invasion and tumorigenicityVAN ANDEL RES INST·Filed 2005·Granted Jan 18, 2011·1 cites·24 claims
- 0768US7968762B2Immune-compromised transgenic mice expressing human hepatocyte growth factor (hHGF)VAN ANDEL RES INST·Filed 2005·Granted Jun 28, 2011·4 cites·32 claims
- 0868US7183071B2Anthrax lethal factor is a MAPK kinase proteaseUS HEALTH·Filed 2006·Granted Feb 27, 2007·1 cites·10 claims
- 0963US5362716AMethods for stimulating hematopoietic progenitors using hepatocyte growth factor and lymphokinesUS HEALTH·Filed 1992·Granted Nov 8, 1994·32 cites·1 claims
- 1059US7612035B2Inhibition of mitogen-activated protein kinase (MAPK) pathway: a selective therapeutic strategy against melanomaVAN ANDEL RES INST·Filed 2005·Granted Nov 3, 2009·0 cites·9 claims
- 1152US5888965AMethod of stimulating bone marrow regenerationUS HEALTH·Filed 1994·Granted Mar 30, 1999·9 cites·6 claims
- 1250US2007020234A1Inhibition of tumor angiogenesis by combination of thrombospondin-1 and inhibitors of vascular endothelial growth factorVANDE WOUDE GEORGE F·Filed 2004·Application pending·0 cites
- 1349US6150398AMethods for the treatment of cancerUS HEALTH·Filed 1996·Granted Nov 21, 2000·16 cites·40 claims
- 1449US2002054869A1Inhibition of mitogen-activated protein kinase (MAPK) pathway: a selective therapeutic strategy against melanomaFiled 2001·Application pending·0 cites
- 1548US8466339B2Mig-6 knockout mice and elucidation of association of Mig-6 with early onset degenerative joint disease and role as a tumor suppressorZHANG YU-WEN·Filed 2006·Granted Jun 18, 2013·0 cites·23 claims
- 1644US2004136975A1Anthrax lethal factor inhibits tumor growth and angiogenesisFiled 2002·Application pending·0 cites
- 1742US2005118165A1Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factorANDEL INST VAN·Filed 2002·Application pending·0 cites
- 1842US2012100157A1Biomarker and Method for Predicting Sensitivity to MET InhibitorsVANDE WOUDE GEORGE F·Filed 2011·Application pending·0 cites
- 1940US2007297980A1Geldanamycin and Derivatives Inhibit Cancer Invasion and Identify Novel TargetsXIE QIAN·Filed 2005·Application pending·0 cites
- 2036US2003017985A1Molecules that influence pathogen resistanceFiled 2001·Application pending·0 cites
- 2127US6673559B1Met proto-oncogene and a method for predicting breast cancer progressionUS HEALTH·Filed 1992·Granted Jan 6, 2004·4 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when George F. Vande Woude files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →